CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- 4 Exercise or conversion Director acquired 16,233 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,116 shares (option exercise)
- 4 Planned sale Director sold 5,682 shares at $46.63 ($264,952)
- 4 Exercise or conversion Director acquired 16,233 shares (option exercise)
- 4 Exercise or conversion Director acquired 12,174 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,058 shares (option exercise)
- 4 Shares withheld for taxes Chief Financial Officer gave up 703 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 5,704 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,704 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President gave up 19,260 shares (to pay taxes)
- 4 Planned sale Chief Legal Officer sold 13,885 shares at $52.29 ($726,047)
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,323 shares (to pay taxes)
- 4 Planned sale President sold 160,009 shares at $48.84 ($7,814,840)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,278 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,334 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 2,362 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 5,450 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 780 shares (to pay taxes)
- 4 Open-market sale Director sold 23,853 shares at $29.49 ($703,306)
Page 3 of 54 · 1,067 filings